Recruiting Epilepsy Studies in Hartford
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures...
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
Cenobamate (YKP3089) is a small molecule approved in the United States (US), Europe and several other countries around the world for the treatment of Partial-Onset (focal) seizures in adult subjects (...
About Epilepsy Clinical Trials in Hartford
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects about 50 million people worldwide. Treatment includes antiseizure medications, surgery, and neurostimulation devices.
There are currently 2 epilepsy clinical trials recruiting participants in Hartford, CT. These studies are seeking a combined 230 participants. Research is being sponsored by SK Life Science, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Epilepsy Clinical Trials in Hartford — FAQ
Are there epilepsy clinical trials in Hartford?
Yes, there are 2 epilepsy clinical trials currently recruiting in Hartford, CT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hartford?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you about next steps.
Are clinical trials in Hartford free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hartford studies also compensate for your time and travel.
What epilepsy treatments are being tested?
The 2 active trials in Hartford are testing new therapies including novel drugs, biologics, and treatment approaches for epilepsy.
Data updated March 2, 2026 from ClinicalTrials.gov